Coverage Policy and Use Beyond the FDA-Approved Label

Author: William T. McGivney PhD
View More View Less

William T. McGivney, PhD, is the Chief Executive Officer of the National Comprehensive Cancer Network and a recognized expert in coverage policy and drug and device regulatory policy. Before joining the NCCN in 1997, Dr. McGivney directed the Division of Health Care Technology at the American Medical Association and worked for Aetna Health Plans as Vice President for Clinical and Coverage Policy. Awarded the FDA Commissioner's Medal of Appreciation in 1989, Dr. McGivney has served on numerous national boards and committees. He earned his PhD at the University of North Carolina at Chapel Hill and completed a postdoctoral fellowship in the Department of Psychiatry at the Harvard Medical School.

  • 1.

    Schrag D. The price tag on progress: Chemotherapy for colorectal cancer. N Engl J Med 2004;351:317-319.

  • 2.

    Berenson A. Cancer drugs offer hope, but at a huge expense. The New York Times, July 12, 2005.

  • 3.

    Harris G. US weighs not paying for all uses of some drugs. The New York Times, January 30, 2004.

All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 79 48 0
PDF Downloads 30 7 2
EPUB Downloads 0 0 0